Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Identification of novel cellular transcription factors that regulate early promoters of human papillomavirus types 18 and 16.

Sichero L, Sobrinho JS, Villa LL.

J Infect Dis. 2012 Sep 15;206(6):867-74. doi: 10.1093/infdis/jis430. Epub 2012 Jun 27.

PMID:
22740717
3.

[Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].

Velazquez Torres A, Gariglio Vidal P.

Rev Invest Clin. 2002 May-Jun;54(3):231-42. Review. Spanish.

PMID:
12183893
4.

Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia.

Vrtačnik Bokal E, Kocjan BJ, Poljak M, Bogovac Z, Jančar N.

J Obstet Gynaecol Res. 2010 Dec;36(6):1204-13. doi: 10.1111/j.1447-0756.2010.01316.x.

PMID:
21114573
6.

Differences in Transcriptional Activity of Human Papillomavirus Type 6 Molecular Variants in Recurrent Respiratory Papillomatosis.

Measso do Bonfim C, Simão Sobrinho J, Lacerda Nogueira R, Salgado Kupper D, Cardoso Pereira Valera F, Lacerda Nogueira M, Villa LL, Rahal P, Sichero L.

PLoS One. 2015 Jul 7;10(7):e0132325. doi: 10.1371/journal.pone.0132325. eCollection 2015 Jul 7.

7.

Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants.

López-Saavedra A, González-Maya L, Ponce-de-León S, García-Carrancá A, Mohar A, Lizano M.

Arch Virol. 2009;154(5):747-54. doi: 10.1007/s00705-009-0362-4. Epub 2009 Apr 1.

PMID:
19337781
8.

MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors.

Peter M, Rosty C, Couturier J, Radvanyi F, Teshima H, Sastre-Garau X.

Oncogene. 2006 Sep 28;25(44):5985-93. Epub 2006 May 8.

PMID:
16682952
9.

A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.

Yew CW, Lee P, Chan WK, Lim VK, Tay SK, Tan TM, Deng LW.

Cancer Res. 2011 Nov 1;71(21):6696-707. doi: 10.1158/0008-5472.CAN-11-1271. Epub 2011 Sep 9.

10.

E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.

Wu L, Goodwin EC, Naeger LK, Vigo E, Galaktionov K, Helin K, DiMaio D.

Mol Cell Biol. 2000 Oct;20(19):7059-67.

11.

Regulation of human papillomavirus type 16 early gene expression in trophoblastic and cervical cells.

Weyn C, Vanderwinden JM, Rasschaert J, Englert Y, Fontaine V.

Virology. 2011 Mar 30;412(1):146-55. doi: 10.1016/j.virol.2010.12.056. Epub 2011 Jan 26.

12.

New variants of human papillomavirus type 18 identified in central Brazil.

Cerqueira DM, Raiol T, Véras NM, von Gal Milanezi N, Amaral FA, de Macedo Brígido M, Martins CR.

Virus Genes. 2008 Oct;37(2):282-7. doi: 10.1007/s11262-008-0263-8. Epub 2008 Jul 29.

PMID:
18663566
13.

Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.

Lee K, Lee AY, Kwon YK, Kwon H.

Biochem Biophys Res Commun. 2011 Aug 26;412(2):328-33. doi: 10.1016/j.bbrc.2011.07.098. Epub 2011 Jul 29.

PMID:
21821000
14.

Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1.

Lace MJ, Anson JR, Klingelhutz AJ, Harada H, Taniguchi T, Bossler AD, Haugen TH, Turek LP.

Carcinogenesis. 2009 Aug;30(8):1336-44. doi: 10.1093/carcin/bgp150. Epub 2009 Jun 18.

PMID:
19541854
15.

High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.

de Boer MA, Jordanova ES, Kenter GG, Peters AA, Corver WE, Trimbos JB, Fleuren GJ.

Clin Cancer Res. 2007 Jan 1;13(1):132-8.

16.
17.

Variants of the long control region of human papillomavirus type 16.

Kurvinen K, Yliskoski M, Saarikoski S, Syrjänen K, Syrjänen S.

Eur J Cancer. 2000 Jul;36(11):1402-10.

PMID:
10899654
18.

Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.

Nürnberg W, Artuc M, Vorbrueggen G, Kalkbrenner F, Moelling K, Czarnetzki BM, Schadendorf D.

Br J Cancer. 1995 May;71(5):1018-24.

19.

TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.

Donalisio M, Cornaglia M, Landolfo S, Lembo D.

Virus Res. 2008 Mar;132(1-2):253-6. doi: 10.1016/j.virusres.2007.12.003.

PMID:
18206261
20.

Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal.

Pista A, Oliveira A, Barateiro A, Costa H, Verdasca N, Paixão MT.

J Med Virol. 2007 Dec;79(12):1889-97.

PMID:
17935194

Supplemental Content

Support Center